- Home
- BHVN vs BCRX Comparison
BHVN vs BCRX Comparison
Compare BHVN & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BHVN | BCRX |
|---|---|---|
| Founded | 2013 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 2022 | 1995 |
Fundamental Metrics
Financial Performance| Metric | BHVN | BCRX |
|---|---|---|
| Price | $13.75 | $7.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 11 |
| Target Price | ★ $23.73 | $20.45 |
| AVG Volume (30 Days) | 3.0M | ★ 5.5M |
| Earning Date | 10-29-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 26.08 | ★ 381.40 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $25,186,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.71 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.99 | $6.23 |
| 52 Week High | $18.24 | $11.22 |
Technical Indicators
Market Signals| Indicator | BHVN | BCRX |
|---|---|---|
| Relative Strength Index (RSI) | 47.39 | 41.71 |
| Support Level | $13.56 | N/A |
| Resistance Level | $15.27 | $8.83 |
| Average True Range (ATR) | 1.00 | 0.38 |
| MACD | -0.12 | -0.03 |
| Stochastic Oscillator | 12.82 | 17.74 |
Price Performance
Historical ComparisonAbout BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.